EMA Guide On Adverse Reaction Questionnaires Retains Challenging Requirements
When finalizing its guidance on the use of follow-up questionnaires to obtain additional information on an adverse reaction, the European Medicines Agency has addressed some of industry's concerns, but retained requirements for detailed analysis and outcome indicators.
